BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Plüß M, Piantoni S, Tampe B, Kim AHJ, Korsten P. Belimumab for systemic lupus erythematosus - Focus on lupus nephritis. Hum Vaccin Immunother 2022;:2072143. [PMID: 35588699 DOI: 10.1080/21645515.2022.2072143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen H, Chiang Y, Hong Y, Shieh T, Huang T, Ali M, Chang H, Wang K, Hsia S. Quercetin Ameliorates Renal Injury and Pyroptosis in Lupus Nephritis through Inhibiting IL-33/ST2 Pathway In Vitro and In Vivo. Antioxidants 2022;11:2238. [DOI: 10.3390/antiox11112238] [Reference Citation Analysis]
2 Nasonov EL, Soloviev SK, Arshinov AV. Systemic lupus erythematosus: history and modernity. Naučno-praktičeskaâ revmatologiâ 2022;60:397-412. [DOI: 10.47360/1995-4484-2022-397-412] [Reference Citation Analysis]
3 Plüß M, Piantoni S, Wincup C, Korsten P. Rapid Response of Refractory Systemic Lupus Erythematosus Skin Manifestations to Anifrolumab-A Case-Based Review of Clinical Trial Data Suggesting a Domain-Based Therapeutic Approach. J Clin Med 2022;11. [PMID: 35743519 DOI: 10.3390/jcm11123449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]